MétaCan
Menu
Back to cohort

Tiotropium Initiation and Dementia Risk in Chronic Obstructive Pulmonary Disease

2025· article· en· W4410484242 on OpenAlexaffabout
Che‐Yuan Wu, Tetyana Kendzerska, Christa Wang, Lisa Y. Xiong, Jodi D. Edwards, Peter P. Liu, Refik Saskin, Walter Swardfager

Bibliographic record

VenueJAMA Internal Medicine · 2025
Typearticle
Languageen
FieldMedicine
TopicChronic Obstructive Pulmonary Disease (COPD) Research
Canadian institutionsOttawa HospitalUniversity of OttawaUniversity Health NetworkUniversity of TorontoInstitute for Clinical Evaluative SciencesToronto Rehabilitation InstituteSunnybrook Health Science Centre
Fundersnot available
KeywordsMedicineAnticholinergicDementiaCOPDTiotropium bromideHazard ratioCohortInternal medicinePropensity score matchingPopulationDiseaseLungConfidence interval

Abstract

fetched live from OpenAlex

Importance: Long-acting muscarinic antagonists (LAMAs), such as tiotropium, are inhaled anticholinergic bronchodilators. However, there is limited clinical evidence examining whether LAMAs may have clinically meaningful central anticholinergic effects, such as increased dementia risk. Objective: To determine the association between tiotropium initiation and dementia risk in older adults with chronic obstructive pulmonary disease (COPD). Design, Setting, and Participants: This population-based, active-comparator, new-user cohort study used linkable administrative databases from Ontario, Canada, with a target trial emulation framework. The cohort included new users of tiotropium monotherapy or a long-acting β2-agonist plus inhaled corticosteroid (LABA-ICS) who were 66 years or older with COPD and without dementia, from September 4, 2004, to February 29, 2012. The follow-up period was up to 10 years from treatment initiation. Analyses were conducted from May 13, 2024, to March 6, 2025. Exposures: Tiotropium monotherapy initiators were compared with LABA-ICS initiators. The primary analysis used an intention-to-treat exposure definition. Main Outcomes and Measures: Incident dementia was determined using a validated algorithm. A 1-year lag time was implemented to mitigate reverse causality and to account for disease latency. Cause-specific hazard ratios (HRs) with death as a competing risk were obtained from Cox models with propensity score fine stratification weights. Weighted incidence rate differences (IRDs) per 1000 person-years were calculated. Results: Among 30 960 tiotropium monotherapy initiators and 19 530 LABA-ICS initiators, the mean (SD) age was 75.1 (6.7) years and 46.7% were female. Over a median (IQR) follow-up period of 7.59 (3.91-10.0) years from treatment initiation, tiotropium monotherapy vs LABA-ICS initiation was associated with a small increase in dementia risk per 1000 person-years (incidence rates, 29.6 [95% CI, 28.8-30.4] vs 27.4 [95% CI, 26.4-28.3]; IRD, 2.3 [95% CI, 1.0-3.5]; HR, 1.09 [95% CI, 1.04-1.14]). The secondary as-treated analysis showed no significant association per 1000 person-years (incidence rates, 24.1 [95% CI, 22.2-26.0] vs 21.4 [95% CI, 18.5-24.3]; IRD, 2.7 [95% CI, -0.8 to 6.1]; HR, 1.11 [95% CI, 0.93-1.32]). Conclusions and Relevance: In this cohort study, among older adults with COPD, the small absolute rate increase in incident dementia associated with tiotropium monotherapy vs LABA-ICS was of questionable clinical importance, particularly when weighed against the established clinical benefits of tiotropium.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.095
Threshold uncertainty score0.899

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.012
GPT teacher head0.302
Teacher spread0.290 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueJAMA Internal MedicineSame topicChronic Obstructive Pulmonary Disease (COPD) ResearchFrench-language works237,207